share_log

Insider Buying: EuroEyes International Eye Clinic Founder Bought HK$448k Of Shares

インサイダー取引:EuroEyes International Eye Clinicの創業者が株式448k香港ドルを購入しました

Simply Wall St ·  2023/10/25 18:05

Even if it's not a huge purchase, we think it was good to see that Jörn Jörgensen, the Founder of EuroEyes International Eye Clinic Limited (HKG:1846) recently shelled out HK$448k to buy stock, at HK$4.39 per share. Nevertheless, it only increased their shareholding by a minuscule percentage, and it wasn't a massive purchase by absolute value, either.

See our latest analysis for EuroEyes International Eye Clinic

EuroEyes International Eye Clinic Insider Transactions Over The Last Year

Notably, that recent purchase by Founder Jörn Jörgensen was not the only time they bought EuroEyes International Eye Clinic shares this year. Earlier in the year, they paid HK$5.50 per share in a HK$4.4m purchase. That means that an insider was happy to buy shares at above the current price of HK$4.40. Their view may have changed since then, but at least it shows they felt optimistic at the time. To us, it's very important to consider the price insiders pay for shares. It is generally more encouraging if they paid above the current price, as it suggests they saw value, even at higher levels.

In the last twelve months EuroEyes International Eye Clinic insiders were buying shares, but not selling. You can see a visual depiction of insider transactions (by companies and individuals) over the last 12 months, below. By clicking on the graph below, you can see the precise details of each insider transaction!

insider-trading-volume
SEHK:1846 Insider Trading Volume October 25th 2023

EuroEyes International Eye Clinic is not the only stock that insiders are buying. For those who like to find winning investments this free list of growing companies with recent insider purchasing, could be just the ticket.

Does EuroEyes International Eye Clinic Boast High Insider Ownership?

For a common shareholder, it is worth checking how many shares are held by company insiders. I reckon it's a good sign if insiders own a significant number of shares in the company. It's great to see that EuroEyes International Eye Clinic insiders own 57% of the company, worth about HK$836m. This kind of significant ownership by insiders does generally increase the chance that the company is run in the interest of all shareholders.

So What Does This Data Suggest About EuroEyes International Eye Clinic Insiders?

The recent insider purchase is heartening. And an analysis of the transactions over the last year also gives us confidence. Once you factor in the high insider ownership, it certainly seems like insiders are positive about EuroEyes International Eye Clinic. That's what I like to see! If you are like me, you may want to think about whether this company will grow or shrink. Luckily, you can check this free report showing analyst forecasts for its future.

If you would prefer to check out another company -- one with potentially superior financials -- then do not miss this free list of interesting companies, that have HIGH return on equity and low debt.

For the purposes of this article, insiders are those individuals who report their transactions to the relevant regulatory body. We currently account for open market transactions and private dispositions of direct interests only, but not derivative transactions or indirect interests.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

これらの内容は、情報提供及び投資家教育のためのものであり、いかなる個別株や投資方法を推奨するものではありません。 更に詳しい情報
    コメントする